CLNN
Clene
Stock NASDAQ – Stock Market Prices, News & Analysis
Entreprise biopharmaceutique engagée dans le développement de traitements utilisant la nanotechnologie pour les maladies neurodégénératives.
Clene
CLNN
Entreprise biopharmaceutique engagée dans le développement de traitements utilisant la nanotechnologie pour les maladies neurodégénératives.
Price history of Clene
Price history of Clene
Performance & Momentum
Clene Inc Highlights Clinical Progress and Growth Plans
Clene Inc (NASDAQ: CLNN), a biopharmaceutical company focused on neurodegenerative diseases, recently presented new clinical data at the ECTRIMS 2025 congress. The data showcased the positive effects of its CNM-Au8® treatment on brain metabolism in patients with multiple sclerosis and Parkinson's disease. Additionally, the company will participate in major sector events, including the Emerging Growth Conference and the Maxim Growth Summit, to promote its innovative pipeline and boost investor visibility. These initiatives reflect Clene's strong momentum in a competitive industry, potentially supporting market confidence and positively impacting its stock price.
Similar stocks to Clene
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
